CUSABIO Expands Flexible Antibody Expression for AI-Driven Antibody Discovery

Summary

CUSABIO has expanded its recombinant antibody expression service to support AI-driven antibody discovery with flexible options for multiple sequence scales and expression volumes. The expansion includes optional validation services such as ELISA, SPR/LSPR, and BLI.